255 related articles for article (PubMed ID: 22044356)
1. Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.
Vadlapudi AD; Vadlapatla RK; Mitra AK
Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):8-18. PubMed ID: 22044356
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic developments in cytomegalovirus retinitis.
Hoffman VF; Skiest DJ
Expert Opin Investig Drugs; 2000 Feb; 9(2):207-20. PubMed ID: 11060672
[TBL] [Abstract][Full Text] [Related]
4. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cytomegalovirus retinitis with oral valganciclovir in an acquired immunodeficiency syndrome patient unresponsive to combination antiretroviral therapy.
Lee CH; Bright DC; Ferrucci S
Optometry; 2006 Apr; 77(4):167-76. PubMed ID: 16567278
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group.
Jabs DA; Dunn JP; Enger C; Forman M; Bressler N; Charache P
Arch Ophthalmol; 1996 Jul; 114(7):809-14. PubMed ID: 8660163
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options for resistant cytomegalovirus retinitis.
Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
[TBL] [Abstract][Full Text] [Related]
8. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
Plosker GL; Noble S
Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
10. Current therapeutic challenges in the treatment of cytomegalovirus retinitis.
Spector SA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S32-5. PubMed ID: 9058616
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus Retinitis: A Review.
Port AD; Orlin A; Kiss S; Patel S; D'Amico DJ; Gupta MP
J Ocul Pharmacol Ther; 2017 May; 33(4):224-234. PubMed ID: 28355091
[TBL] [Abstract][Full Text] [Related]
12. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
Smith IL; Taskintuna I; Rahhal FM; Powell HC; Ai E; Mueller AJ; Spector SA; Freeman WR
Arch Ophthalmol; 1998 Feb; 116(2):178-85. PubMed ID: 9488269
[TBL] [Abstract][Full Text] [Related]
13. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
15. Changing therapeutic paradigms in CMV retinitis in AIDS.
Piper H; Ciulla TA; Danis RP; Pratt LM
Expert Opin Pharmacother; 2000 Dec; 1(7):1343-52. PubMed ID: 11249469
[TBL] [Abstract][Full Text] [Related]
16. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
17. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
19. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).
Roels P
Optometry; 2004 Oct; 75(10):624-8. PubMed ID: 15508863
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Au Eong KG; Beatty S; Charles SJ
Postgrad Med J; 1999 Oct; 75(888):585-90. PubMed ID: 10621898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
